Protocol implementation in anesthesia: beta-blockade in non-cardiac surgery patients.

Area of Science:

• Cardiology
• Anesthesiology
• Critical Care Medicine

Background:

• Perioperative myocardial ischemia and/or infarction (PMI/I) is a significant concern in surgical patients.
• An audit revealed under-use of prophylactic beta-adrenergic blocking drugs (BADs) in intensive care unit (ICU) patients with PMI/I.

Purpose of the Study:

• To develop and assess an institutional protocol for identifying at-risk patients.
• To standardize and improve the management of prophylactic beta-adrenergic blockade.
• To evaluate the efficiency of program implementation in reducing PMI/I.

Main Methods:

• A protocol was implemented in May 2003, involving metoprolol administration pre-, intra-, and post-operatively.
• Patients with PMI/I requiring ICU admission were tracked from January 2002 to December 2004.
• Program efficiency was evaluated by comparing data from September 2003 and February 2004.

Main Results:

• The use of BADs increased from 31% to 39% in eligible patients post-implementation.
• The incidence of PMI/I patients admitted to ICU decreased from 2.6 to 1.6 per 1,000 surgical cases (P=0.025).
• Overall hospital PMI/I incidence decreased from 5.9 to 2.0 per 1,000 surgical cases (P<0.001).

Conclusions:

• Standardization of perioperative beta-blockade increased metoprolol use in at-risk individuals.
• The protocol successfully reduced PMI/I diagnoses and ICU admissions.
• This initiative improved patient outcomes by enhancing prophylactic BADs management.